Is Smoking History the Truly Best Biomarker for Immune Checkpoint Inhibitor Treatment in Advanced Non-Small Cell Lung Cancer?

ESMO Open - United Kingdom
doi 10.1136/esmoopen-2018-000421
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ